T 1828/20 (Rifaximin formulation / ALPHASIGMA) of 27.09.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T182820.20220927
- Date of decision
- 27 September 2022
- Case number
- T 1828/20
- Online on
- 5 October 2022
- Petition for review of
- -
- Application number
- 11776879.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE
- Applicant name
- Alfasigma S.p.A.
- Opponent name
- Sandoz GmbH
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.